作者
Zhuo‐Yu An,Yejun Wu,Yu Hou,Heng Mei,Weixia Nong,Wenqian Li,Hu Zhou,Ru Feng,Jianping Shen,Jun Peng,Hai Zhou,Yi Liu,Yongping Song,Linhua Yang,Meiyun Fang,Jianyong Li,Yunfeng Cheng,Peng Liu,Yajing Xu,Zhao Wang,Yi Luo,Zhen Cai,Hui Liu,Jingwen Wang,Juan Li,Xi Zhang,Zimin Sun,Xiaoyu Zhu,Xin Wang,Rong Fu,Liang Huang,Shaoyuan Wang,Tonghua Yang,Liping Su,Liangming Ma,Xiequn Chen,Dai‐Hong Liu,Hongxia Yao,Jia Feng,Hongyu Zhang,Ming Jiang,Zeping Zhou,Wensheng Wang,Xu‐Liang Shen,Yangjin Baima,Yueying Li,Qian‐Fei Wang,Qiu-Sha Huang,Haixia Fu,Xiaolu Zhu,Song Wu,Qian Jiang,Hao Jiang,Lu Jin,Xiang‐Yu Zhao,Ying‐Jun Chang,Tao Wu,Yaozhu Pan,Lin Qiu,Da Gao,Anting Jin,Wei Li,Sujun Gao,Lei Zhang,Ming Hou,Xiao‐Jun Huang,Xiaohui Zhang
摘要
Rare but critical bleeding events in primary immune thrombocytopenia (ITP) present life-threatening complications in patients with ITP, which severely affect their prognosis, quality of life, and treatment decisions. Although several studies have investigated the risk factors related to critical bleeding in ITP, large sample size data, consistent definitions, large-scale multicenter findings, and prediction models for critical bleeding events in patients with ITP are unavailable. For the first time, in this study, we applied the newly proposed critical ITP bleeding criteria by the International Society on Thrombosis and Hemostasis for large sample size data and developed the first machine learning (ML)-based online application for predict critical ITP bleeding. In this research, we developed and externally tested an ML-based model for determining the risk of critical bleeding events in patients with ITP using large multicenter data across China. Retrospective data from 8 medical centers across the country were obtained for model development and prospectively tested in 39 medical centers across the country over a year. This system exhibited good predictive capabilities for training, validation, and test datasets. This convenient web-based tool based on a novel algorithm can rapidly identify the bleeding risk profile of patients with ITP and facilitate clinical decision-making and reduce the occurrence of adversities.